Let’s Meet the Virologists

LMtV Episode 75: Let’s Meet the Virologist Alberto Lopez-Munoz

We talk with Alberto Lopez-Munoz, a a postdoctoral fellow in the Yewdell lab at the National Institute of Allergy and Infectious Diseases, who studies immunomodulation by SARS-CoV-2 nucleocapsid protein.

LMtV Episode 74: Let’s Meet the Virologist Amy Davis

We talk with Amy Davis, a graduate student in the Schultz-Cherry lab at St Jude Children's Research Hospital, who studies astrovirus infection of the central nervous system.

LMtV Episode 73: Let’s Meet the Virologist Grant Butschek

We talk with Grant Butschek, a graduate student in the Pekosz lab at Johns Hopkins University, who is studying how temperature differences in the upper and lower respiratory tract alter virus infection.

LMtV Episode 72: Let’s Meet the Virologist Hannah Wallace

We talk with Hannah Wallace, a graduate student in the Russell lab at Memorial University in St John's, who is investigating how Hepatitis C virus induces pyroptosis.

LMtV Episode 71: Let’s Meet the Virologist Jonathan Joyce

We talk with Jonathan Joyce, a graduate student in the Bertke lab at Virginia Polytechnic Institute and State University, who is investigating how SARS-CoV-2 infects the nervous system.

LMtV Episode 70: Let’s Meet the Virologist Ashish Srivastava

We talk with Dr. Ashish Srivastava, a faculty member at Amity Institute of Virology and Immunology in India, who uses CRISPR-Cas detection and nanopore sequencing technologies to identify and characterize known and novel viruses that affect plant crops.

LMtV Episode 69: Let’s Meet the Virologist Aaron Embry

We talk with Aaron Embry, a graduate student in the Gammon and Alto labs at University of Texas Southwest Medical Center, who studies bacterial effector proteins that overcome barriers to arbovirus infection.

LMtV Episode 68: Let’s Meet the Virologist Sriram Kumar

We talk with Sriram Kumar, a graduate student in the Ludwig/Brunotte lab at the Institute of Virology, who investigates the virus specific therapeutic potential of different IFN alpha subtypes for influenza virus and SARS-CoV-2.